INTRODUCTION RESULTS

1) Patient characteristics
Mean age of patients was 60.4 years and 92.9% of patients were male. Twenty cases (71.4%) of arm vein bypass were performed for limb salvage of the patients with critical limb ischemia (Rutherford category 4 and 5) and 8 (28.6%) for the patients with severe claudication (Rutherford category 3). The reasons for absence of GSV are listed as follows: 14 patients (50.0%) had undergone previous bypass procedures, 12 patients (42.9%) had inadequate GSV size or length and 2 patients (7.1%) had thrombus in their GSVs ( Table 1) .
The bypass grafts were composed of single arm vein segments in 17 cases (60.7%) and composite veins in 11 cases (39.3%) ( Table 2 ). The most common inflow artery was the common femoral artery (11 cases, 39.3%) and most common outflow arteries were the anterior tibial and
The objective of this study was to present the long-term results of arm vein graft in LEAB. Arm vein was used for 12 initial procedures and for 16 revision procedures of previous bypass grafts and/or endovascular procedures. Assessment of vein availability and its quality was performed by vein mapping with preoperative routine duplex ultrasonog raphy. The saphenous vein was considered unusable if it was too small (<2 mm) or occluded due to thrombus on duplex ultrasonography. Therefore, if preoperative scan showed that bilateral saphenous veins were not suitable for bypass in all patients, arm veins were scanned for bypass conduit with duplex ultrasonography. Arm veins were regarded as suitable vein grafts when the measured diameters were at least 2 mm. Vein mapping was performed by registered vascular technologists marking the courses of cephalic and/ or basilic veins from the wrist to the axillary fossa.
MATERIALS AND METHODS
All LEAB patients with arm vein grafts underwent duplex ultrasonography to evaluate graft patency at postoperative 1, 6, 12 months and every 6 to 12 months thereafter.
This study used definitions and classification of all criteria as those recommended by the Ad Hoc Committee on Reporting Standards appointed by the Society of Vascular Surgery and the North American chapter of the International Society of Cardiovascular Surgery [10] .
2) Statistical analysis
Primary, primary-assisted, secondary patency and limb salvage rates were calculated using the Kaplan-Meier method. Log-rank test was used to examine differences between each group. Student's t-test was used to compare continuous variables. Statistical analysis was performed with IBM SPSS Statistics ver. 22.0 (IBM Co., Armonk, NY, USA). P-values of <0.05 were considered as statistically significant. posterior tibial arteries (8 cases each, 28.6%) ( Table 3) .
2) Morbidity and mortality
The overall perioperative morbidity was reported in 4 patients (14.3%). It included acute myocardial infarction (n=1, 3.6%), stroke (n=2, 7.1%), and postoperative bleeding (n=1, 3.6%), while no morbidity was associated with the arm vein harvest procedure in our study. The 30-day mortality rate was 0%. During the mean follow-up period of 41.5±46.9 month (range, 1-138 months), 3 patients (10.7%) died from combined medical illness of cerebral hemorrhage, gastrointestinal bleeding, and aspiration pneumonia.
3) Graft patency and limb salvage (Fig. 2) .
DISCUSSION
The first study of lower limb bypass with arm vein conduit was reported in 1969 [11] . After that, several studies from the past decade have introduced good long term patency rates and limb salvage rates in lower limb bypass with arm vein conduit [8, [12] [13] [14] [15] [16] . Some groups have encouraged the use arm veins as the first alternative conduit when the ipsilateral GSV is absent due to the low morbidity of arm vein harvesting and for preservation of the contralateral GSV [8, 12, 13] . These studies showed that contralateral GSVs were subsequently used for either contralateral infrainguinal limb bypass (20%-23%) or coronary bypass (2%-3%).
Recent studies have reported that LEAB using arm vein conduits showed 3-year graft patency and limb salvage rates ranging from 40% to 73% and 63% to 92%, respectively [8, 12, 13, 16] . In our series, the overall 3-year patency and limb salvage rates were 60.9% and 94.4%, respectively. These results are comparable to other previous studies.
Despite the above evidence supporting the efficacy of arm vein grafts in patients with LEAB, it remains an infrequently used procedure because of concerns about the need to make composite veins in some patients to obtain adequate length. This has been considered a limitation to the use of arm vein graft as the venovenostomy has been shown to negatively affect the patency of these grafts [15] . However our study shows no negative effect on patency or limb salvage rate of composite vein grafts compared to single segment grafts.
We preferred basilic veins to cephalic veins as graft source. In our study, only 4 cephalic vein grafts were used for bypass. The cephalic vein is often inadequate for conduit due to prior puncture or trauma. Some authors suggest that the location of the basilic vein limits its utility as vascular access for hemodialysis and is thus less likely to be traumatized or can be avoided for venous puncture compared to the cephalic vein [17] . Arm veins or polytetrafluoroethylene (PTFE) grafts with adjunctive procedures could be considered as alternative bypass conduits when all saphenous veins are inadequate for LEAB bypass [18] . Previous studies showed that results from infrapopliteal bypass using prosthetic graft have been less satisfactory than those obtained with arm vein (Table 4) [8, 12, 16, [19] [20] [21] [22] [23] [24] [25] . In our institute, we prefer arm vein graft as a first choice of alternative graft in infrapopliteal bypass in the absence of adequate saphenous vein. In our study, subanalysis of infrapopliteal arm vein bypasses (23 cases) showed that 3-year primary patency, secondary patency, and limb salvage rates were 50.5%, 63.3%, 92.9%, respectively. By comparison, a meta-analysis of PTFE infrapopliteal bypass published in 2003 introduced 3-year primary patency, secondary patency, and limb salvage rates of 41%, 51%, and 66%, respectively [18] . The above results suggest that the arm vein is a favorable alternative conduit in infrapopliteal bypass when no saphenous veins are available.
The present study has several limitations. First, this study was a retrospective design and there could be some selection bias in the patients. Second, it was composed of small sample size, by which statistical power might be weak, although it is the largest case series reported in Korea. At last, there is no comparison group such as infrapopliteal bypass using prosthetic graft, so we presented some literature review and compared indirectly with several previous studies.
CONCLUSION
Our results showed that the arm vein was a useful alternative conduit when great or SSV was not available during LEAB. In case of short length of vein, composite vein grafts are also a reliable conduit.
